Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Fragile X syndrome (FXS) is a significant cause of intellectual disability and autism, while Fragile X Premutation -Associated Conditions (FXPAC) are a significant cause of morbidity and mortality globally. This study assessed the level of knowledge and perceptions about FXS and FXPAC among doctors in Nigeria. It was a web-based, cross-sectional study conducted among a cohort of doctors in Nigeria. Socio-demographic profile, knowledge of FXS, perceptions about FXS, knowledge of FXPAC, experience of doctors, and suggested ways of improving knowledge and management of FXS were obtained. Data were analyzed using STATA 16.0. Chi-square and Fisher's exact tests of association were used to determine the association between variables, with the significance level set at p < 0.05. A total of 274 doctors participated in the study. A significant proportion of respondents had limited knowledge about the clinical features of FXS. Nine of ten (90.0%) participants with good knowledge of FXS had good perceptions of FXS management. This was statistically significant (p < 0.001). There was a high nonresponse rate to what FXPAC is (164/274, 59.9%) among the respondents because of insufficient knowledge. Suboptimal knowledge of FXS which influenced perception was noted among doctors. More strategies should be considered to improve doctors' knowledge and management of FXS and FXPAC in Nigeria.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11608841 | PMC |
| http://dx.doi.org/10.1111/cge.14619 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Alzheimer disease is (sometimes) highly heritable: Drivers of variation in heritability estimates for binary traits, a systematic review.
PLoS Genet
September 2025
Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
Estimating heritability has been fundamental in understanding the genetic contributions to complex disorders like late-onset Alzheimer's disease (LOAD) and provides a rationale for identifying genetic factors associated with disease susceptibility. While numerous studies have established substantial genetic contribution for LOAD, the interpretation of heritability estimates remains challenging. These challenges are further complicated by the binary nature of LOAD status, where estimation and interpretation require additional considerations.
View Article and Find Full Text PDFEntangled pathways: navigating mental healthcare dynamics in Abeokuta.
Discov Ment Health
August 2025
Department of Sociology and Anthropology, Obafemi Awolowo University, Ile-Ife, Nigeria.
Mental healthcare among the Yoruba in Abeokuta, Nigeria, extends beyond hospitals to encompass a range of traditional and faith-based practices. This study examines the various forms of mental healthcare available in Abeokuta, the motivations behind their use, and how engagement with multiple treatment systems shapes recovery experiences. Drawing on nine months of ethnographic fieldwork across purposively selected biomedical, Ibile (traditional), and Aladura (faith-based) mental health facilities, the study employed standard ethnographic methods (interview, observations, and discussion) to gather qualitative data.
View Article and Find Full Text PDFAdvances in Non-statin Lipid Therapies: A Narrative Review of Evolving Strategies for Cardiovascular Risk Reduction.
Am J Cardiovasc Drugs
August 2025
Richmond University Medical Center/Mount Sinai, Staten Island, NY, USA.
Despite the well-established benefits of statin therapy in reducing atherosclerotic cardiovascular disease (ASCVD) risk, many patients fail to achieve recommended low-density lipoprotein cholesterol (LDL-C) targets or experience statin intolerance, necessitating alternative approaches. This review examines advances in non-statin lipid-lowering therapies, focusing on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (monoclonal antibodies and inclisiran), bempedoic acid, and other non-statin lipid medications. We evaluate their mechanisms of action, clinical efficacy, and safety profiles on the basis of landmark trials.
View Article and Find Full Text PDFEvaluating community engagement strategies in COVID-19: insights from a National Quasi-Experimental Intervention.
BMC Public Health
August 2025
Department of Human Anatomy, Faculty of Basic Medical Sciences, University of Maiduguri, Maiduguri, Borno State, Nigeria.
Background: Community engagement is essential during crises such as the COVID-19 pandemic. However, the effectiveness of community engagement during this pandemic, especially in low- and middle-income countries, has not been seriously investigated.
Objective: The effectiveness of a comprehensive intervention program in managing COVID-19 in Iran emphasizes community involvement and multifaceted strategies.
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE.
Eur J Prev Cardiol
August 2025
Division of Diabetes, Endocrinology and Metabolism, Imperial College London at Hammersmith Campus, Imperial College London, 6th Floor, Commonwealth Building, Du Cane Road, London W12 OHS, UK.
Aims: Lipoprotein(a) (Lp(a)) is a genetic causal risk factor for atherosclerotic cardiovascular disease (ASCVD), irrespective of ancestry. INTERASPIRE is an international cohort study of secondary prevention conducted in 14 countries from all 6 WHO regions.
Methods And Results: In a sub-study of seven countries (China, Colombia, Kenya, Nigeria, Malaysia, Poland, UAE), physicians involved in INTERASPIRE were contacted to investigate ASCVD knowledge and elicit perspectives on Lp(a) testing and management.